Patents

Hepatocurative effect of emblica officinalis against CYP 450 bio-activation hepatotoxicity of drugs

The present invention relates to a composition useful for hepatocurative effect against CYP 450 bio-activation hepatotoxicity induced by drugs, said composition comprising an extract from Emblica officinalis and optionally pharmaceutically acceptable additives and method of treating drug induced hepatotoxicity.

Filing Date: 27-03-2002

Issue Date: 21-02-2006

Patent No: US7001619 [USA]

Application No: 106119

Inventor(s): Johri, Rakesh Kamal; Abdullah, Sheikh Tasaduq; Singh, Kuldeep; Gupta, Devinder Kumar; Kapahi, Bal Krishan; Mondhe, Dilip Manikrao; Jain, Satinder Mohan; Suri, Om Parkash; Bedi, Kasturi Lal; Qazi, Ghulam Nabi

Licensing Option: Laboratory willing to jointly develop technology with industrial partner.

Implementing institute: CSIR-Indian Institute of Integrative Medicine [CSIR-IIIM]

Funding agency: Council of Scientific and Industrial Research (CSIR)

IPC Classification: A61K9/00, A61K9/20, A61K 35/00, A61K 35/78

US9899687: Process for the synthesis of nitrogen-doped carbon electro-catalyst

US9650330: A mild and general process for the synthesis of aryl sulfones

US9198986: WDR13 as a novel biomarker useful for treating diabetes and cancer

US8628961: Small molecule antagonists of phosphatidylinositol-3,4,5-triphosphate (PIP3) and uses thereof

Search form